American Century Companies Inc. Boosts Holdings in AVANOS MEDICAL, INC. $AVNS

American Century Companies Inc. boosted its position in shares of AVANOS MEDICAL, INC. (NYSE:AVNS) by 17.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 122,947 shares of the company’s stock after acquiring an additional 17,835 shares during the period. American Century Companies Inc. owned 0.27% of AVANOS MEDICAL worth $1,762,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AVNS. State of Wyoming raised its stake in AVANOS MEDICAL by 132.0% during the 4th quarter. State of Wyoming now owns 5,137 shares of the company’s stock worth $82,000 after acquiring an additional 2,923 shares during the period. Tower Research Capital LLC TRC raised its stake in AVANOS MEDICAL by 493.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company’s stock worth $129,000 after acquiring an additional 6,714 shares during the period. Heritage Family Offices LLP bought a new stake in AVANOS MEDICAL during the 1st quarter worth approximately $146,000. EP Wealth Advisors LLC raised its stake in AVANOS MEDICAL by 14.6% during the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company’s stock worth $161,000 after acquiring an additional 1,289 shares during the period. Finally, Mariner LLC raised its stake in AVANOS MEDICAL by 18.0% during the 4th quarter. Mariner LLC now owns 10,655 shares of the company’s stock worth $170,000 after acquiring an additional 1,625 shares during the period. Institutional investors own 95.17% of the company’s stock.

Insiders Place Their Bets

In other AVANOS MEDICAL news, Director Gary Blackford purchased 40,000 shares of AVANOS MEDICAL stock in a transaction that occurred on Wednesday, August 13th. The shares were bought at an average price of $10.99 per share, for a total transaction of $439,600.00. Following the completion of the transaction, the director owned 40,000 shares of the company’s stock, valued at approximately $439,600. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 2.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on AVNS shares. Zacks Research upgraded shares of AVANOS MEDICAL to a “hold” rating in a research note on Tuesday, August 12th. Wall Street Zen cut shares of AVANOS MEDICAL from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of “Hold”.

AVANOS MEDICAL Trading Up 0.5%

AVANOS MEDICAL stock opened at $11.93 on Tuesday. The stock has a market cap of $553.74 million, a P/E ratio of -1.19 and a beta of 1.12. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.64 and a quick ratio of 1.58. AVANOS MEDICAL, INC. has a 1 year low of $9.30 and a 1 year high of $25.36. The firm’s 50 day moving average price is $11.62 and its 200-day moving average price is $12.77.

AVANOS MEDICAL (NYSE:AVNS) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The company had revenue of $175.00 million for the quarter, compared to the consensus estimate of $165.50 million. AVANOS MEDICAL had a negative net margin of 66.89% and a positive return on equity of 6.16%. During the same quarter in the previous year, the business earned $0.34 EPS. AVANOS MEDICAL has set its FY 2025 guidance at 0.750-0.950 EPS. On average, equities analysts predict that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current fiscal year.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.